3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow Nonmalignant Neoplasm: new trials by email Literature Review of Nonmalignant Neoplasm trials Research Report on Nonmalignant Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Donor Stem Cell Transplant After Busulfan, Fludarabine, Methylprednisolone, and Antithymocyte Globulin in Treating Patients With Bone Marrow Failure Syndrome nonmyeloablative allogeneic hematopoietic stem cell transplantation - Leukemia, Myelodysplastic Syndromes | Phase 2 | Completed | Asan Medical Center | 15 | 2008-04-01 | 2015-12-31 |
| RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS Rapamycin - Nonmalignant Neoplasm, Tuberous Sclerosis | Phase 2 | Completed | Dana-Farber Cancer Institute | 36 | 2005-12-20 | 2022-04-25 |
| Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer anti-thymocyte globulin, busulfan, carboplatin - Chronic Myeloproliferative Disorders, Leukemia | Phase 2 / Phase 3 | Completed | Roswell Park Cancer Institute | 361 | 1998-10-19 | 2021-08-13 |
Neoplasms (3) · Anemia, Aplastic (2) · Anemia, Refractory (2) · Leukemia (2) · Myelodysplastic Syndromes (2) · Anemia, Refractory, with Excess of Blasts (1) · Angiomyolipoma (1) · Blast Crisis (1) · Burkitt Lymphoma (1) · Congenital Abnormalities (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Hemoglobinuria, Paroxysmal (1) · Immunoblastic Lymphadenopathy (1) · Intraocular Lymphoma (1) · Leukemia, Biphenotypic, Acute (1)
Neoplasms by Histologic Type (3) · Anemia (2) · Bone Marrow Diseases (2) · Bone Marrow Failure Disorders (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Anemia, Hemolytic (1) · Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Blood Protein Disorders (1) · Bone Marrow Neoplasms (1) · Carcinogenesis (1) · Cardiovascular Diseases (1) · Cell Transformation, Neoplastic (1)
Antilymphocyte Serum (1) · Busulfan (1) · Carboplatin (1) · Cyclophosphamide (1) · Etoposide (1) · Melphalan (1) · Sirolimus (1) · Thiotepa (1) · Whole-Body Irradiation (1) · fludarabine phosphate (1)
Asan Medical Center (1) · Dana-Farber Cancer Institute (1) · Roswell Park Cancer Institute (1)
United States (2) · South Korea (1)
Kyoo H. Lee, MD (1) · Philip L. McCarthy, MD (1) · Sandra Dabora, MD, PhD (1)
P30CA006516 (1), R01CA107164 (1)